182 related articles for article (PubMed ID: 21805030)
41. The clinical implications of hepatitis B virus genotype: Recent advances.
Lin CL; Kao JH
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():123-30. PubMed ID: 21199523
[TBL] [Abstract][Full Text] [Related]
42. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
43. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M
J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
[TBL] [Abstract][Full Text] [Related]
44. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
45. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
[TBL] [Abstract][Full Text] [Related]
46. Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection.
Sezaki H; Kobayashi M; Hosaka T; Someya T; Akuta N; Suzuki F; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Sato J; Kumada H
J Gastroenterol; 2004 Jun; 39(6):550-6. PubMed ID: 15235872
[TBL] [Abstract][Full Text] [Related]
47. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
48. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
Tu H; Gao HF; Ma GH; Liu Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
[TBL] [Abstract][Full Text] [Related]
49. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma.
Bläckberg J; Kidd-Ljunggren K
J Med Virol; 2003 Sep; 71(1):18-23. PubMed ID: 12858404
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
[TBL] [Abstract][Full Text] [Related]
51. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 Sep; 194(5):594-9. PubMed ID: 16897657
[TBL] [Abstract][Full Text] [Related]
52. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
Pasquinelli C; Bhavani K; Chisari FV
Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
[TBL] [Abstract][Full Text] [Related]
53. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
[TBL] [Abstract][Full Text] [Related]
54. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
55. Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma.
Sitia G; Iannacone M; Guidotti LG
J Hepatol; 2013 Nov; 59(5):1135-8. PubMed ID: 23742914
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transduction in vitro and in vivo.
Hösel M; Lucifora J; Michler T; Holz G; Gruffaz M; Stahnke S; Zoulim F; Durantel D; Heikenwalder M; Nierhoff D; Millet R; Salvetti A; Protzer U; Büning H
Hepatology; 2014 Jun; 59(6):2110-20. PubMed ID: 24425003
[TBL] [Abstract][Full Text] [Related]
57. [Establishment of hepatitis B virus (HBV) chronic infection mouse model by in vivo transduction with a recombinant adeno-associated virus 8 carrying 1. 3 copies of HBV genome (rAAN8-1. 3HBV)].
Dong XY; Yu CJ; Wang G; Tian WH; Lu Y; Zhang FW; Wang W; Wang Y; Tan WJ; Wu XB
Bing Du Xue Bao; 2010 Nov; 26(6):425-31. PubMed ID: 21344744
[TBL] [Abstract][Full Text] [Related]
58. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
[TBL] [Abstract][Full Text] [Related]
59. Chronic hepatitis B virus infection and occurrence of hepatocellular carcinoma in tree shrews (Tupaia belangeri chinensis).
Yang C; Ruan P; Ou C; Su J; Cao J; Luo C; Tang Y; Wang Q; Qin H; Sun W; Li Y
Virol J; 2015 Feb; 12():26. PubMed ID: 25889678
[TBL] [Abstract][Full Text] [Related]
60. [Immunosuppressant dexamethasone can significantly extend the expression of hepatitis B virus antigens in the HBV mouse model by hydrodynamic transfection method].
Guo YJ; Wang W; Sun SH; Zeng DB; Zhao GY; Yu H; Guo Y; Tan WJ; Lu SC; Zhou YS
Bing Du Xue Bao; 2010 Jan; 26(1):20-6. PubMed ID: 20329554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
